Effectiveness of Chatbot-Supported Web Program in Postpartum Care

NCT ID: NCT07148778

Last Updated: 2025-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical study was to evaluate the effectiveness of a web-based "Postpartum Care Package" program developed for postpartum women and delivered via a chatbot, and to examine its effects on the postpartum health of mothers and newborns.

The key questions it aims to answer are:

* What is the impact of the chatbot-supported web-based "Postpartum Care Package" program on the postpartum health of mothers and newborns?
* Does the chatbot-supported web-based "Postpartum Care Package" program increase women's accessibility and availability of postpartum care resources?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Care Web-based Training Chatbot-Based Training

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

postpartum care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1: Chatbot-Assisted Web-Based Postpartum Care Package Program

Group Type EXPERIMENTAL

Educational intervention

Intervention Type BEHAVIORAL

In this study, a web-based postpartum care package program supported by a chatbot will be administered to the intervention group.

A pre-test will be administered to participants in the intervention group within 24-48 hours after birth.

Participants in this group will be informed that they must watch the videos in the educational modules until the sixth week postpartum. Reminder messages will also be sent to participants via the website, email, and phone calls (between days 7 and 14 postpartum and week 3 postpartum). Participants who have completed the module training will be eligible for post-tests at 6 weeks postpartum and 3 months postpartum.

Arm 2: Standard Postpartum Care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educational intervention

In this study, a web-based postpartum care package program supported by a chatbot will be administered to the intervention group.

A pre-test will be administered to participants in the intervention group within 24-48 hours after birth.

Participants in this group will be informed that they must watch the videos in the educational modules until the sixth week postpartum. Reminder messages will also be sent to participants via the website, email, and phone calls (between days 7 and 14 postpartum and week 3 postpartum). Participants who have completed the module training will be eligible for post-tests at 6 weeks postpartum and 3 months postpartum.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have given birth between the 37th and 41st weeks of pregnancy,
* Be primigravida,
* Have not been diagnosed with a high-risk pregnancy,
* Have an educational level of primary school or above,
* Have no communication difficulties or mental disabilities,
* Have access to equipment (mobile phone, computer, tablet, internet) for web-based education,
* Have experienced no complications in the mother or baby during pregnancy, childbirth, or the postpartum period,
* Voluntarily agree to participate in the study,

Exclusion Criteria

* Women who moved outside the province where the study was conducted during the implementation period,
* Women who voluntarily withdrew from the study,
* Women who did not participate in any phase of the study will not be included in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emine Ilkin Aydin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emine Ilkin Aydin

Lecturer

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emine ILKIN AYDIN, Lecturer

Role: PRINCIPAL_INVESTIGATOR

Yozgat Bozok University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emine ILKIN AYDIN, Lecturer

Role: CONTACT

Phone: +905456281694

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17/04/2025-04/1228-AYBU-001

Identifier Type: -

Identifier Source: org_study_id